Abstract
A comparison was performed of structure with gastric ulcerogenic activity of a range of acidic and one group of non-acidic (tetrazine) non-steroid anti-inflammatory (NSAI) drugs with the object of establishing the physico-chemical properties of these drugs involved in gastric ulceration. The results with non-acetylated salicylate analogues show that an increase in lipophilic properties of 3-substituted salicylates was associated with decreased gastric ulceration. The converse was, however, observed with 4- and 5-substituted salicylates, i.e. increased lipid solubility was associated with enhanced gastric ulceration. 0-Acetylation increased the ulcerogenic activity of all salicylates (except 4-t-butyl derivative). Lipid solubility was also found to influence the gastric ulcerogenic activity of other NSAI drugs in different ways. It is also apparent that electronic factors (which reflect changes in the dissociation constants) and the position of electron-withdrawing substituents on aromatic groups variously influences the ulcerogenic activity in different groups of NSAI drugs.
The presence of the carboxylic acid moiety is a major factor in ulcerogenesis by acidic NSAI drugs. Laser Raman spectroscopy of these drugs shows that there is a profound alteration in the frequency of absorption of the carbonyl group in the solid state and in concentrated solutions at pH 6–7. Such changes reflect an intermolecular interaction between the carbonyl and hydroxyl groups of carboxylic acids and suggest that these drugs exist as dimers under these conditions. Dimeric NSAI drugs may initiate gastric damage by the breaking of bonds between the dimers and reformation of bonds between the drugs and membrane phospholipids so disrupting the latter and leading to permeability changes.
Similar content being viewed by others
References
R. Menguy,Acute Gastric Mucosal Bleeding, Ann. Rev. Med.23, 297–312 (1972).
A.R. Cooke,Drugs and Gastric Damage, Drugs11, 36–44 (1976).
K.W. Anderson,Some Biochemical and Physiological Aspects of Salicylate-Induced Gastric Lesions in Laboratory Animals, in: Salicylates,An International Symposium. (Eds. A.St.J. Dixon, B.K. Martin, M.J.H. Smith and P.H.N. Wood; Churchill, London, 1963), pp. 217–223.
K.D. Rainsford andM.W. Whitehouse,Gastric Irritancy of Aspirin and its Congeners: Anti-Inflammatory Activity Without this Side-Effect, J. Pharm. Pharmac.28, 599–601 (1976).
K.D. Rainsford,The Biochemical Pathology of Aspirin-Induced Gastric Damage, Agents and Actions5, 326–344 (1975).
K.D. Rainsford,A Synergistic Interaction between Aspirin, or other Non-Steroidal Anti-Inflammatory Drugs, and Stress Which Produces Severe Gastric Damage in Rats and Pigs, Agents and Actions5, 553–558 (1975).
K.D. Rainsford,The Comparative Gastric Ulcerogenic Activities of Non-Steroid Anti-Inflammatory Drugs, Agents and Actions7, 573–577 (1977).
K.D. Rainsford,Comparative Studies of Gastric Ulcerogenesis by Non-Steroid Anti-Inflammatory Drugs: Effects of Fenclofenac, Proc. Roy. Soc. Med. Suppl.6, 4–10 (1977).
K.D. Rainsford,Gastrointestinal Damage from Aspirin and Non-Steroidal Anti-Inflammatory Drugs: Thoughts for Safer Therapy from Biochemical Studies, Drugs Exptl. Clin. Res.2, 121–132 (1977).
K.D. Rainsford,Gastrointestinal and other Side-Effects from the Use of Aspirin and Related Drugs: Biochemical Studies on the Mechanisms of Gastrotoxicity, inProceedings of the Symposium on Aspirin and Related Drugs: Their Actions and Uses. (Eds. K.D. Rainsford, K. Brune and M.W. Whitehouse; Agents and Actions, Suppl. 1, pp. 59–70, 1977).
K.D. Rainsford,Aspirin and Gastric Ulceration: Light and Electronmicroscopic Observations in a Model of Aspirin Plus Stress-Induced Ulcerogenesis, Br. J. exp. Path.58, 215–219 (1977).
K.D. Rainsford,The Role of Aspirin in Gastric Ulceration: Some Factors Involved in the Development of Gastric Mucosal Damage Induced by Aspirin in Rats Exposed to Various Stress Conditions, Am. J. dig. Dis.23, 521–530 (1978).
K.D. Rainsford,Electronmicroscopic Observations on the Effects of Orally Administered Aspirin and Aspirin-Bicarbonate Mixtures on the Development of Gastric Mucosal Damage in the Rat, Gut16, 514–527 (1975).
K.D. Rainsford,The Relationship between Distribution of Salicylates in the Gastrointestinal Tract and Blood and Development of Gastric Damage after Oral Administration of Aspirin and Aspirin Bicarbonate Mixtures in Rats, Clin. exp. Pharmacol. Physiol.2, 40–41 (1975).
K.D. Rainsford andM.W. Whitehouse,Non-Steroid Anti-Inflammatory Drugs: Combined Assay for Anti-Edemic Potency and Gastric Ulcerogenesis in the Same Animal, Life Sciences21, 371–378 (1977).
C. Hansch, A. Leo, S.H. Unger, K.H. Kim, D. Nikaitani andE.J. Lien,‘Aromatic’ Substituent Constants for Structure-Activity Correlations, J. Med. Chem.16, 1207–1216 (1973).
G.B. Barlin andD.D. Perrin,Prediction of the Strength of Organic Acids, Quarterly Reviews20, 75–101 (1966).
C. Hansch,Quantitative Structure-Activity Relationships in Drug Design, in:Drug. Design. (Ed. E.J. Ariëns; Academic Press, New York, 1971), pp. 271–342.
G. Kortüm,W. Vogel andK. Andrusson,Dissociation Constants of Organic Acids in Aqueous Solution, Int. Union of Pure Appl. Chem. (Butterworths, London, 1961).
Personal Communication, Dr.J.W. James, Nicholas Research Institute.
A. Albert andE.P. Serjeant,Ionization Constants of Acids and Bases. (Wiley, New York, 1962).
L.S. Schanker, P.A. Shore, B.B. Brodie andC.A.M. Hogben,Absorption of Drugs from the Stomach I. The Rat, J. Pharm. exp. Therap.120, 528–539 (1957).
Chemical Society Special Reports Nos. 17 and 25Stability Constants.
C. Hansch andK.N. von Kaulla,Fibrinolytic Congeners of Benzoic and Salicylic Acid. A Mathematical Analysis of Correlation between Structure and Activity, Biochem. Pharmac.19, 2193–2220 (1970).
P. Moser, K. Jäkel, P. Krupp, R. Menassé andA. Sallmann,Structure-Activity Relations of Analogs of Phenylbutazone, Eur. J. Med. Chem.10, 613–617 (1975).
P.A. Shore, B.B. Brodie andC.A.M. Hogben,The Gastric Secretion of Drugs: A pH Partition Hypothesis, J. Pharm. exp. Therap.119, 361–369 (1957).
K.D. Rainsford andK. Brune,Role of the Parietal Cell in Gastric Damage Induced by Aspirin and Related Drugs: Implications for Safer Therapy, Med. J. Aust.1, 881–883 (1976).
J.W. Horodniak, E.D. Matz, D.T. Walz, R.D. Cramer III, B.M. Sutton, C.E. Berkhoff, J.E. Zarembo andA.D. Bender,Inhibition of Prostaglandin Synthetase and Carrageenin-Induced Edema by Analogs of Flufenamic Acid, Drugs, expt. Clin. Res.2, 35–45 (1977).
S.A. Lang, B.D. Johnson, E. Cohen, A.E. Sloboda andE. Greenblatt,Aryl s-Tetrazines with Anti-inflammatory Activity, J. Med. Chem.19, 1404–1409 (1979).
H. Terada, S. Muraoka andT. Fujita,Structure-Activity Relationships of Fenamic Acids, J. Med. Chem.17, 330–334 (1974).
A.R. Fesht andA.J. Kirby,Structure and Mechanism in Intramolecular Catalysis. The Hydrolysis of Substituted Aspirins, J. Am. Chem. Soc.89, 4853–4857 (1967).
K. Brune, A. Schweitzer andH. Eckert,Parietal Cells Trap Salicylates during Absorption, Biochem. Pharmac.26, 1735–1740 (1977).
K.D. Rainsford andK. Brune,Selective Cytotoxic Actions of Aspirin on Parietal Cells: A Principal Factor in the Early Stages of Aspirin-Induced Gastric Damage, Archiv. Toxicol.40, 143–150 (1978).
P.J. Wheatley,The Crystal and Molecular Structure of Aspirin, J. Chem. Soc.1964, 6036–6048 (1964).
H. Bundgaard andK. Larsen,Intramolecular and Intermolecular Transformations of Aspirin in Nonhydroxylic Solvents, J. Pharm. Sci.65, 776–778 (1976).
A. Lespagnol andM. Bar,Sur l'hydrolyse d'homologues superieurs de l'acide acetylsalicylique, Mem. Soc. Chim.5, 1360–1365 (1938).
T.Y. Shen,Anti-Inflammatory Agents, in:Topics in Medicinal Chemistry, vol. I (Eds. J.L. Rabinowitz and R.M. Myerson; Interscience, New York), pp. 29–78.
T.Y. Shen,Discovery and Characterization of Sulindac and its Metabolites, in:Clinoral in the Treatment of Rheumatic Disorders (Eds. E.S. Huskisson and P. Franchimont; Raven Press, New York, 1976), pp. 1–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rainsford, K.D. Structure-activity relationships of non-steroid anti-inflammatory drugs 1. Gastric ulcerogenic activity. Agents and Actions 8, 587–605 (1978). https://doi.org/10.1007/BF01998888
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01998888